Home › Funds › MUFG Securities EMEA plc › GILD

MUFG Securities EMEA plc position in GILD

GILEAD SCIENCES INC · Health Care

MUFG Securities EMEA plc reported holding 380,376 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$56.7M, representing 0.62% of its reported portfolio and ranking #41 among its reported holdings. MUFG Securities EMEA plc has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)380.38K sh
Reported value held$56.70M
Portfolio Weight0.62%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How MUFG Securities EMEA plc's GILD position evolved

MUFG Securities EMEA plc first disclosed a stake in GILD in Q3 2023 at 4,903 shares (US$367K). The position peaked in Q2 2026 at 588,075 shares, worth US$74.3M. Across 13 filings, MUFG Securities EMEA plc increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 380,376 shares valued at US$56.7M — a reduction of -207,699 shares quarter over quarter.. Notable position changes include a 4681% increase in Q2 2024 (shares rose 22% over the following quarter), a 2889% increase in Q3 2025 (shares rose 10% over the following quarter), a 926% increase in Q1 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.90K $367.43K New
Q4 2023 3.63K $293.90K Reduce
Q1 2024 4.03K $295.27K Add
Q2 2024 192.71K $13.22M Add
Q3 2024 136.27K $11.42M Reduce
Q4 2024 139.81K $12.91M Add
Q1 2025 121.80K $13.65M Reduce
Q2 2025 3.67K $407.12K Reduce
Q3 2025 109.75K $12.18M Add
Q4 2025 50.86K $6.24M Reduce
Q1 2026 521.86K $72.73M Add
Q2 2026 588.08K $74.30M Add
Q3 2026 380.38K $56.70M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has MUFG Securities EMEA plc held GILD?

MUFG Securities EMEA plc has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MUFG Securities EMEA plc's current position in GILD?

As of Q3 2026, MUFG Securities EMEA plc holds 380.38K shares of GILD (GILEAD SCIENCES INC), valued at $56.70M, representing 0.62% of its reported portfolio and ranking #41.

Has MUFG Securities EMEA plc been buying or selling GILD?

In the latest 13F filing (Q3 2026), MUFG Securities EMEA plc reduced its position in GILD. The position peaked in Q2 2026 at 588.08K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.